Lower lithium prices weigh on Albermarle as UBS cuts price target
Chemical company Albermarle Corp. (ALB) saw its common stock price drop 4.4% on Tuesday as the biggest decliner in the S&P 500 . UBS cut its price target for Albermarle to $130 a share from $140 on lower lithium prices, which have fallen amid lower-than-expected demand for electric vehicles (EVs). "We expect ALB stock to remain under pressure until there is visibility on 1) lithium price floor, 2) any supply response to lower prices...and 3) EV demand outlook," UBS analyst Joshua Spector said in a research note. UBS reiterated a neutral rating on Albermarle amid expectations that the lithium market will remain volatile.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-05-23 1137ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Apple: We Expect New Models and New Chip to Spur Return to iPad Growth
-
Palantir Earnings: AI Platform Drives Strong Start to 2024
-
What I Hope My 14-Year-Old Learned at Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Amazon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
3 Stocks With High Dividend Yields That Warren Buffett Likes
-
How to Invest Like Warren Buffett
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability